We are live on ! Find out more
CCA

Canyon Capital Advisors Portfolio holdings

AUM $882M
1-Year Est. Return 62.77%
This Fund
S&P 500
This Quarter Est. Return
+2.01%
1 Year Est. Return
+62.77%
3 Year Est. Return
+78.01%
5 Year Est. Return
+85.45%
10 Year Est. Return
+347.5%
AUM
$1.01B
AUM Growth
+$337M
Cap. Flow
+$175M
Cap. Flow %
17.27%
Top 10 Hldgs %
89.63%
Holding
32
New
2
Increased
2
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
SDRL icon
Seadrill
SDRL
+$186M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$26.4M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$21.1M
4
ATVI
Activision Blizzard
ATVI
+$16.1M

Top Sells

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$58.3M

Sector Composition

Rank Sector Weight
1 Energy 31.73%
2 Real Estate 18.25%
3 Materials 17.49%
4 Miscellaneous 14.17%
5 Healthcare 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SDRL icon
1
Seadrill
SDRL
$2.98B
$208M 20.48%
5,031,783
+5,004,161
+18,117% +$186M
CBL
2
CBL Properties
CBL
$1.7B
$185M 18.25%
8,396,293
– –
BERY
3
DELISTED
Berry Global Group, Inc.
BERY
$177M 17.49%
3,000,469
– –
NE.WS icon
4
Noble Corporation PLC Tranche 1 Warrants
NE.WS
– –
0
– –
VAL icon
5
Valaris
VAL
$5.99B
$62.7M 6.19%
996,957
– –
NE.WS.A icon
6
Noble Corporation PLC Tranche 2 Warrants
NE.WS.A
– –
0
– –
THC icon
7
Tenet Healthcare
THC
$21.5B
$47.1M 4.65%
578,832
-818,950
-59% -$58.3M
NE icon
8
Noble Corp
NE
$7.31B
$45.1M 4.45%
1,091,318
– –
AMBP icon
9
Ardagh Metal Packaging
AMBP
$3.07B
$38.2M 3.77%
10,154,743
– –
HZNP
10
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$25.7M 2.54%
+250,000
New +$26.4M
ATVI
11
DELISTED
Activision Blizzard
ATVI
$21.1M 2.08%
250,000
+198,700
+387% +$16.1M
SGEN
12
DELISTED
Seagen Inc. Common Stock
SGEN
$20.5M 2.02%
+106,363
New +$21.1M
RSI icon
13
Rush Street Interactive
RSI
$3.05B
$17.9M 1.77%
5,735,284
– –
RUN icon
14
Sunrun
RUN
$2.11B
$15.8M 1.55%
882,600
– –
CRC icon
15
California Resources
CRC
$4.64B
$6.15M 0.61%
226,349
– –
AAC.WS
16
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
– –
0
– –
LCAAW
17
DELISTED
L Catterton Asia Acquisition Corp Warrant
LCAAW
– –
0
– –
FLYX.WS icon
18
flyExclusive Inc Warrants
FLYX.WS
$2.21M
– –
0
– –
GFX.WS
19
DELISTED
Golden Falcon Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
GFX.WS
– –
0
– –
ALLG.WS
20
DELISTED
Allego N.V. Warrants
ALLG.WS
– –
0
– –
DCFCW
21
DELISTED
Tritium DCFC Limited Warrant
DCFCW
– –
0
– –
BAERW icon
22
Bridger Aerospace Warrant
BAERW
$10.4M
– –
0
– –
PRPC.WS
23
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
– –
0
– –
JWSM.WS
24
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
– –
0
– –
APGB.WS
25
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
– –
0
– –
1
2

Similar funds

TAM
TCP Asset Management Columbus, Ohio $882M AUM 21.79% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
FFG
Fiduciary Financial Group San Rafael, California $882M AUM 23.98% 1-Year Est. Return
1IA
1834 Investment Advisors Milwaukee, Wisconsin $883M AUM 23.82% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
CIPU
Caledonia Investments plc (UK) London England, United Kingdom $883M AUM 2.08% 1-Year Est. Return
FSCM
Front Street Capital Management Missoula, Montana $881M AUM 86.5% 1-Year Est. Return
AIA
Arbor Investment Advisors Winston Salem, North Carolina $883M AUM 17.9% 1-Year Est. Return

Canyon Capital Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Canyon Capital Advisors held 32 positions worth $1.01B, up 50% from $677M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Canyon Capital Advisors deployed $175M of net new capital in Q2 2023, opening 2 new positions and adding to 2 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 250,000 shares worth $25.7M.

By sector, the portfolio is most concentrated in Energy at 32% of assets, up from 17% a quarter earlier, followed by Real Estate and Materials.

On the sell side, the largest reduction was Tenet Healthcare, an estimated $58.3M trimmed.

  • Canyon Capital Advisors's largest Q2 2023 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 250,000 shares worth $25.7M.
  • Canyon Capital Advisors added most to Seadrill in Q2 2023, an estimated $186M increase.
  • Canyon Capital Advisors's biggest Q2 2023 reduction was Tenet Healthcare, cutting an estimated $58.3M.
  • Canyon Capital Advisors's ten largest holdings make up 90% of its $1.01B portfolio in Q2 2023.
  • Canyon Capital Advisors opened 2 new positions and closed 0 in Q2 2023.
  • Canyon Capital Advisors's portfolio value rose 50% quarter-over-quarter to $1.01B.

Based on Canyon Capital Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.